Table 2.
Characteristics of population subgroups in the study.
| Controls (n = 13) | Obese (n = 31) | Sarcopenic (n = 21) | Sarcopenic-obese (n = 12) | |
|---|---|---|---|---|
| Age (years) | 75.92 ± 4.44* | 72.96 ± 9.35+¥ | 85.33 ± 7.14*+ | 80.58 ± 9.96¥ |
| Glycemia (mg/dl) | 101.31 ± 27.81 | 96.54 ± 13.95 | 97.57 ± 43.08 | 104.75 ± 31.99 |
| Total cholesterol (mg/dl) | 160.92 ± 51.64 | 178.65 ± 53.62* | 130.76 ± 33.46* | 158.75 ± 38.43 |
| LDL cholesterol (mg/dl) | 93.22 ± 36.58* | 103.58 ± 47.09+ | 63.52 ± 32.88*+ | 83.83 ± 32.7 |
| HDL cholesterol (mg/dl) | 43.69 ± 13.51 | 48.44 ± 18.21* | 37.76 ± 19.9* | 47.08 ± 17.22 |
| Triglycerides (mg/dl) | 119.92 ± 72.6 | 138.63 ± 59.93 | 149.76 ± 90.83 | 139.75 ± 70.65 |
| Creatinine (umol/L) | 80.25 ± 13.36 | 96.31 ± 64.57 | 89.43 ± 58.19 | 82.5 ± 33.24 |
| SBP (mmHg) | 133 ± 27.92 | 135 ± 13.44* | 120.95 ± 17.33* | 132.83 ± 13.33 |
| DBP (mmHg) | 79.15 ± 13.91* | 76.25 ± 8.18+ | 65.33 ± 9.33*+¥ | 75.25 ± 10.19¥ |
| PP (mmHg) | 53.62 ± 19.23 | 58.75 ± 11.2 | 55.62 ± 14.1 | 57.58 ± 13.27 |
| MAP (mmHg) | 97.1 ± 17.82* | 95.83 ± 8.77+ | 83.87 ± 10.67*+¥ | 94.44 ± 9.45¥ |
| HR (bpm) | 73.85 ± 7.59 | 71.52 ± 7.72 | 74.76 ± 13.74 | 77.33 ± 7.96 |
| CAVI (U) | 9.55 ± 1.77* | 9.35 ± 1.97+ | 11.31 ± 2.58*+ | 10.77 ± 2.72 |
| cfPWV (m/s) | 10.4 ± 2.93* | 11.12 ± 3.88+ | 11.89 ± 3.13¥ | 15.18 ± 8.44*+¥ |
| Waist Circumference (cm) | 85.81 ± 6.19* | 110.30 ± 11.33*+ | 81.12 ± 9.31+¥ | 107.17 ± 8.43*¥ |
| Fat Mass (Kg) | 16.98 ± 8.47* | 31.06 ± 10.26*+ | 11.29 ± 5.75+¥ | 29.46 ± 7.40*¥ |
LDL, low-density lipoprotein; HDL, high-density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; MAP, mean arterial pressure; HR, heart rate; cfPWV, carotid-femoral pulse wave velocity; CAVI, cardio ankle vascular index.
Groups that share the same apex symbol (*, +, or ¥) for a given variable significantly differ (p < 0.05).